Tirzepatide
US$ 23.99
glp 1 agonist function GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 receptor agonists | How
Description
doi: 10.1038/npp.2015.47, 61 HealthU
All GLP-1RAs [reviewed in (81)] and, more recently, the dual incretin receptor agonist tirzepatide, have been shown to lower postprandial triglyceride and ApoB-48 levels significantly (82)
Additionally, improved glycemic control further enhances these effects, particularly in patients with type 2 diabetes
It sounds like some Tricare for Life members are in the same boat
The Journal of Law and Economics
For more on Zepbound, see our article Zepbound Canada: Cost, Dosing, and How It Compares to Mounjaro and Wegovy
